T Cell Proliferative Responses to Glutamic Acid Decarboxylase-65 in IDDM are Negatively Associated with HLA DR3/4

References

• Wicker L. S., Miller B. J., Mullen Y. Transfer of autoimmune diabetes mellitus wih splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986; 35: 855–860
   PubMed Web of Science ®Google Scholar
• Bendelac A., Carnaud C., Boitard C., Bach J. F. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates: requirement for both L3T4+ and lyt-2+ T cells. J. Exp. Med 1987; 166: 823–832
   PubMed Web of Science ®Google Scholar
• Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619–633
   PubMed Web of Science ®Google Scholar
• Foulis A. K., McGill M., Farquharson M. A. Insulitis in type I (insulin-dependent) diabetes mellitus in man-macrophages, lymphocytes, and interferon-γ containing cells. J. Pathol. 1991; 165: 97–103
   PubMed Web of Science ®Google Scholar
• Sibley R. K., Sutherland D. E.R., Goetz F., Michael A. F. Recurrent diabetes mellitus in the pancreas iso-and allograft. Lab. Invest. 1985; 53: 132–144
   PubMed Web of Science ®Google Scholar
• Santamaria P., Nakhleh R. E., Sutherland D. E., Barbosa J. J. Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 1992; 41: 53–61
   PubMed Web of Science ®Google Scholar
• Stiller C. R., Dupré J., Gent M., et al. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984; 223: 1362–1367
   PubMed Web of Science ®Google Scholar
• Feutren G., Assan R., Karsenty G., et al. Cyclosporin increases the rate and length of remission in insulin-dependent diabetes of recent onset. Lancet 1986; 2: 119–124
   PubMed Web of Science ®Google Scholar
• The Canadian-European Randomized Control Trial Group. Cyclosporin-induced remission of IDDM after early intervention. Diabetes 1988; 37: 1574–1582
   PubMed Web of Science ®Google Scholar
• Ota K., Matsui M., Milford E. L., Mackin G. A., Weiner H. L., Hafler D. A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346: 183–187
   PubMed Web of Science ®Google Scholar
• Pette M., Fujita K., Wilkinson D., et al. Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 1990; 87: 7968–7972
   PubMed Web of Science ®Google Scholar
• Zhang B. J., Markovic-Plese S., Lacet B., Raus J., Weiner H. L., Hafler D. A. Increased frequency of Interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 1994; 179: 973–984
   PubMed Web of Science ®Google Scholar
• Hohlfeld R., Toyka K. V., Heininger K., Grosse-Wilde H., Kalies I. Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature 1994; 310: 244–246
   Google Scholar
• Melms A., Chrestel S., Schalke B. C.G., et al. Autoimmune T lymphocytes in myasthenia gravis. J. Clin. Invest. 1989; 83: 785–790
   PubMed Web of Science ®Google Scholar
• Keller R. J. Cellular immunity to human insulin in individuals at high risk for the development of type 1 Diabetes Mellitus. J. Autoimmun. 1990; 3: 321–327
   PubMed Web of Science ®Google Scholar
• Naquet P., Ellis J., Tibensky D., et al. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J. Immunol. 1989; 140: 2569–2578
   Web of Science ®Google Scholar
• Cheung R., Karjalainen J., Vandermeulen J., Singal D. P., Dosch H.-M. T cells from children with IDDM are sensitized to bovine serum albumin. Scand. J. Immunol. 1994; 40: 623–628
   PubMed Web of Science ®Google Scholar
• Karjalainen J., Cheung R., Vandermeulen J., Martin J. M., Knip M., Dosch H. M. T Cell proliferation response against bovine albumin (BSA) follows the natural course and is restricted to the linear ABBOS sequence in insulin dependent diabetes mellitus (abstract). Autoimmunity 1993; 15: 62, (suppl.) (abstract)
   Google Scholar
• Atkinson M. A., Bowman M. A., Kao K. J., et al. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N. Engl. J. Med. 1993; 329: 1853–1858
   PubMed Web of Science ®Google Scholar
• Roep B. O., Arden S. D., de Vries R. R.P., Hutton J. C. T cell clones from a type 1 diabetes patient respond to insulin secretory granule proteins. Nature 1990; 345: 632–634
   PubMed Web of Science ®Google Scholar
• Harrison L. C., Honeyman M. C., DeAizpurua H. J., et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341: 1365–1369
   PubMed Web of Science ®Google Scholar
• De Aizpurua H. J., Honeyman M. C., Harrison L. C. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: Co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes. J. Autoimmun. 1992; 5: 759–770
   PubMed Web of Science ®Google Scholar
• Atkinson M. A., Kaufman D. L., Campbell L., et al. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992; 339: 458–459
   PubMed Web of Science ®Google Scholar
• Honeyman M. C., Cram D. S., Harrison L. C. Glutamic acid decarboxylase 67-reactive T cells: A marker of insulin-dependent diabetes. J. Exp. Med 1993; 177: 535–540
   PubMed Web of Science ®Google Scholar
• Kaufman D. L., Clare-Salzler M., Tian J., et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366: 69–72
   PubMed Web of Science ®Google Scholar
• Tisch R., Yang X.-D., Singer S. M., Liblau R. S., Fugger L., McDevitt H. O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366: 72–75
   PubMed Web of Science ®Google Scholar
• Ho H.-Z., Tiwari J. L., Haile R. W., Terasaki P. I., Morton N. E. HLA-linked and unlinked determinants of multiple sclerosis. Immunogenetics 1982; 15: 509–517
   PubMed Web of Science ®Google Scholar
• Naeim F., Keesey J. C., Hermann C., JR., Lindstrom J., Zeller E., Walford R. L. Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in Myasthenia Gravis. Tissue Antigens 1978; 12: 381–386
   PubMedGoogle Scholar
• Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br. Med. J. 1978; 2: 1326–1328
   PubMed Web of Science ®Google Scholar
• Wolf E., Spencer K. M., Cudworth A. G. The genetic susceptibility to type 1 (insulin-dependent) diabetes: Analysis of the HLA-DR association. Diabetologia. 1983; 24: 224–230
   PubMed Web of Science ®Google Scholar
• Svejgaard A., Jakobsen B. K., Platz P., et al. HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens 1986; 28: 237–244
   PubMedGoogle Scholar
• Bidwell J. L., Bidwell E. A., Savage D. A., Middleton D., Klouda P. T., Bradley B. A. A DNA-RFLP typing system that postively identifies serologically well-defined and illdefined HLA-DR and DQ alleles, including DRw10. Transplantation 1988; 45: 640–646
   PubMed Web of Science ®Google Scholar
• Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantations. Tissue Antigens 1992; 39: 225–235
   PubMed Web of Science ®Google Scholar
• Karlsen A. E., Hagopian W. A., Grubin C. E., et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc. Natl. Acad. Sci. USA. 1991; 88: 8337–8341
   PubMed Web of Science ®Google Scholar
• Moody A. J., Hejnás K. R., Marshall M. O., et al. Isolation by anion-exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in Sf9 insect cells. Diabetologia. 1995; 38: 14–23
   PubMed Web of Science ®Google Scholar
• Böhlen P., Stein S., Dairman W., Udenfriend S. Fluorometric assay of protein in the nanogram range. Arch. Biochem. Biophys. 1973; 155: 213–220
   PubMed Web of Science ®Google Scholar
• Petersen J. S., Hejnás K. R., Moody A. J., et al. Detection of GAD65 antibodies in diabetes and other diseases using a simple radioligand assay. Diabetes 1994; 43: 459–467
   PubMed Web of Science ®Google Scholar
• Roep B. O., Kalian A. A., Hazenbos W. L.W., et al. T cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent onset type 1 diabetes. Lancet 1991; 337: 1439–1441
   PubMed Web of Science ®Google Scholar
• Pette M., Fujita K., Kitze B., et al. Myelin basic proteinspecific T lymphocyte lines from MS patients and healthy individuals. Neurology 1990; 40: 1770–1776
   PubMed Web of Science ®Google Scholar
• Aanstoot H. J., Christgau S., Shi Y., Kim J., Békkeskov S. Comparative analyses of the incidence of GAD65 and 64 kD autoantibodies in newly diagnosed type 1 diabetic patients. Autoimmunity 1993; 15: 67, (suppl.) (abstract)
   PubMed Web of Science ®Google Scholar
• Panina-Bordignon P., Lang R., Van Endert P. M., et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J. Exp. Med. 1995; 181: 1923–1927
   PubMed Web of Science ®Google Scholar